Sanofi, GSK to Supply 200 Million Doses of Covid-19 Vaccine to COVAX Facility
October 28 2020 - 2:50AM
Dow Jones News
By Mauro Orru
Sanofi SA and GlaxoSmithKline PLC signed a supply agreement with
Gavi, the administrator of COVAX Facility, a mechanism for the
procurement and distribution of Covid-19 vaccines, Sanofi said
Wednesday.
The French pharmaceutical company said the two drugmakers intend
to supply 200 million doses of their adjuvanted recombinant
protein-based Covid-19 vaccine to the COVAX Facility.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
October 28, 2020 02:35 ET (06:35 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
